Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,571 Blood Cancer
clinical trials

Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center @ NYU Langone
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
NYP Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Advocate Children's Hospital Oak Lawn
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Medical Center-Mission Bay
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph's Hospital/Children's Hospital-Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Jonnsson Comprehensive Cancer Center / University of Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With 5-azacitidine in Patients With Myelodysplastic Syndromes (MDS)
Status: Enrolling, Phase II
Updated: 4/27/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
TG Therapeutics Investigational Trial Site
mi
from
New York, NY
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Lenalidomide Maintenance in Plasma Cell Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Stanford Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Emily Couric Clinical Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Specialists of North Florida
mi
from
Fleming Island, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University Health Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Northern Utah Associates
mi
from
Ogden, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Status: Enrolling, Phase I
Updated: 12/31/1969
Smilow Cancer Hospital of Yale New Haven
mi
from
New Haven, CT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Status: Enrolling, Phase I
Updated: 12/31/1969
Chao Family Comprehensive Cancer Center, University of California, Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Status: Enrolling, Phase I
Updated: 12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Status: Enrolling, Phase I
Updated: 12/31/1969
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Hendrick Cancer Center
mi
from
Abilene, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
University Cancer Institute, LLC
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Rocky Mountain Cancer Centers, LLP
mi
from
Denver, CO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology, P.A.
mi
from
Harlingen, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Community Health Network
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Cancer Specialists, Llc
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Lancaster Cancer Center
mi
from
Lancaster, PA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Hematology/Oncology Associates of Northern New Jersey, P.A.
mi
from
Morristown, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Northern Westchester Hospital
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
West Ky Hematology Oncology Group Psc
mi
from
Paducah, KY
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Valley Hospital
mi
from
Paramus, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-Paris
mi
from
Paris, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Berkshire Hematology Oncology, PC
mi
from
Pittsfield, MA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology, P.A. - Plano
mi
from
Plano, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-San Antonio Stone Oak
mi
from
San Antonio, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Maine Center for Cancer Medicine
mi
from
Scarborough, ME
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Orchard Healthcare Research Inc.
mi
from
Skokie, IL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology - Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Hematology & Oncology
mi
from
Topeka, KS
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
White Plains Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Shenandoah Oncology P.C
mi
from
Winchester, VA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Cancer Care Associates of York
mi
from
York, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of the Carolinas
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Sarah Cannon Research Inst
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Huntsman Cancer Hospital / University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Texas Oncology - Baylor Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Indiana University Health Goshen Center For Cancer Care
mi
from
Goshen, IN
Click here to add this to my saved trials
Leukemia Clinical Trial
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling, Phase
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Leukemia Clinical Trial
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling, Phase
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Leukemia Clinical Trial
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling, Phase
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Leukemia Clinical Trial
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling, Phase
Updated: 12/31/1969
University of Washington School of Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematologic Neoplasms Clinical Trial
A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Leukemia Clinical Trial
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Leukemia Clinical Trial
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Leukemia Clinical Trial
Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Status: Enrolling, Phase II
Updated: 3/1/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Billings Clinic
mi
from
Billings, MT
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Illinois Cancer Specialists
mi
from
Niles, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens Healthcare Of Atlanta - E
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Enrolling, Phase III
Updated: 12/31/1969
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Seattle Cancer Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
1 … 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 … 116